A	B	C
1	Main
2		Brand Name	Alimta
3		Generic Name	pemetrexed
4		IP	4/25/2008 Paragraph IV was filed. Teva was sued 6/10/2008. Trial date 11/8/2010, 30-month stay expires 10/24/2010. 5,344,932 composition of matter.
5		Clinical Trials
6			p3 studies in gastric and colorectal cancer to begin in 2005
7			Alimta to replace Taxotere in 2nd line NSCLC
8			More convenient administration and better tolerability (less neutropenia), medicare pricing helps too
9
10
11
12			Phase III "CRA8000" Maintenance NSCLC study - ASCO 2009
13			Pemetrexed 13.4 months vs 10.6 for placebo. Squamous had negative outcome.
14			http://meeting.ascopubs.org/cgi/content/short/27/18S/CRA8000